Improvement of Cancer Treatment Processes and Reduction of Cost and Patient Length of Stay in Hospital

被引:0
作者
Rouhani, Zain Al-Abedin [1 ]
Kazemipoor, Hamed [1 ]
Sadeghi, Alireza Mir Mohammad [1 ]
Fallah, Mohammad [1 ]
机构
[1] Islamic Azad Univ, Dept Ind Engn, Cent Tehran Branch, Tehran, Iran
关键词
Cancer; Cost evaluation; House of quality; Length of stay; Simulation; Value engineering;
D O I
10.32592/ircmj.2022.24.9.1948
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Reducing patient length of stay (LOS) in hospitals reduces the high cost of chemotherapy and increases patient satisfaction. Objectives: This study aimed to present a combined model based on value engineering and the house of quality (HOQ) to improve the chemotherapy processes of hospitalized adult patients and reduce LOS and costs. Methods: In this study, a cost and time model of the functions was drawn for the current chemotherapy process, and as a result, the duration and costs of a chemotherapy course were obtained. A simulation model corresponding to the process map was developed and the output was validated. Afterward, using the HOQ method in the pre-study stage and collecting value engineering information, the real needs and wants of patients were transformed into quality characteristics, and by implementing other value engineering steps, 5 scenarios were presented to improve the process and were tested on the validated simulation model. Results: The presented scenarios included the process scenario (17.29% time reduction and $ 537,827 cost reduction), medication delivery scenario (7.3% time reduction and $ 268,231 cost reduction), technology scenario (2% time reduction and $ 59,640 cost reduction), end-of-life scenario (20% reduction in time and no cost savings), home care scenario (14% reduction in time and $ 329,020 cost reduction). Conclusion: By implementing these scenarios and improving the process, the treatment protocol was changed and caused an increase in the value index of the patient's LOS and a decrease in the waiting list for chemotherapy in the above hospital.
引用
收藏
页数:17
相关论文
共 21 条
[1]  
Askarzade E, 2019, MIDDLE EAST J CANCER, V10, P362, DOI 10.30476/mejc.2019.83412.1162
[2]   Extended Model for Integrated Value Engineering [J].
Behncke, Florian G. H. ;
Maisenbacher, Sebastian ;
Maurer, Maik .
2014 CONFERENCE ON SYSTEMS ENGINEERING RESEARCH, 2014, 28 :781-788
[3]   Assessing the effect of interspecies oocyte nucleolar material dosage on embryonic development [J].
Benc, Michal ;
Martinkova, Stanislava ;
Rychtarova, Jana ;
Fulka, Josef, Jr. ;
Bartkova, Alexandra ;
Fulka, Helena ;
Laurincik, Jozef .
THERIOGENOLOGY, 2020, 155 :17-24
[4]  
Çakir Edis E, 2007, TUBERK TORAK, V55, P51
[5]   Health care costs for treatment of disseminated breast cancer [J].
Dahlberg, L. ;
Lundkvist, J. ;
Lindman, H. .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (11) :1987-1991
[6]  
Farokhi Noori M., 2012, Iran J Epidemiol, V8, P62
[7]  
Ghaffari A, 2015, MECH ENG, V14, P139
[8]  
Ginting R, 2020, SONGKLA J SCI TECHNO, V42, P771, DOI DOI 10.14456/sjst-psu.2020.99
[9]   The cost of cancer in Europe 2018 [J].
Hofmarcher, Thomas ;
Lindgren, Peter ;
Wilking, Nils ;
Jonsson, Bengt .
EUROPEAN JOURNAL OF CANCER, 2020, 129 :41-49
[10]  
JebelAmeli M S, 2014, ROLE ACHIEVING GOALS